Edition:
India

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

84.88USD
23 May 2018
Change (% chg)

$0.50 (+0.59%)
Prev Close
$84.38
Open
$84.24
Day's High
$85.00
Day's Low
$83.75
Volume
438,246
Avg. Vol
715,941
52-wk High
$86.38
52-wk Low
$59.64

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $31,180.87
Shares Outstanding(Mil.): 489.11
Dividend: 0.10
Yield (%): 0.66

Financials

  ZTS.N Industry Sector
P/E (TTM): 36.00 30.95 32.75
EPS (TTM): 1.77 -- --
ROI: 14.09 14.84 14.38
ROE: 57.16 16.34 16.07

Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion

Top animal health company Zoetis Inc will buy Abaxis Inc for $1.9 billion, looking to capture a bigger slice of the fast-growing market for diagnostics services that cater to household pets and farm animals.

16 May 2018

REFILE-UPDATE 5-Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 bln

* Zoetis says diagnostics should grow faster than animal health

16 May 2018

BRIEF-Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis

* ZOETIS SAYS UPON DEAL TERMINATION BY ABAXIS OR CO, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY ABAXIS - SEC FILING Source text: (https://bit.ly/2KprpqL) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

16 May 2018

BRIEF-Zoetis To Acquire Abaxis for about $2 Bln In Aggregate

* ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS

16 May 2018

Zoetis to buy Abaxis for $1.9 bln in cash

May 16 Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.

16 May 2018

BRIEF-Zoetis Announces Q1 Earnings Per Share $0.72

* Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S

02 May 2018

BRIEF-Zoetis Inc To Expand Animal Vaccine Research And Manufacturing In Suzhou, China

* ZOETIS INC SAYS TO EXPAND ANIMAL VACCINE RESEARCH AND MANUFACTURING IN SUZHOU, CHINA Source text for Eikon: Further company coverage:

26 Apr 2018

BRIEF-Zoetis Says CEO Juan Alaix's 2017 Total Compensation Was $10.5 Mln Vs $9.5 Mln In 2016

* ZOETIS INC SAYS CEO JUAN RAMÓN ALAIX'S 2017 TOTAL COMPENSATION WAS $10.5 MILLION VERSUS $9.5 MILLION IN 2016 – SEC FILING‍​ Source text (https://bit.ly/2uJV1MK) Further company coverage:

02 Apr 2018

BRIEF-Zoetis Inc Q4 Earnings Per Share $0.16

* ADJUSTED NET INCOME FOR 2017 ‍EXCLUDES ONE-TIME PROVISIONAL NET TAX CHARGE OF $212 MILLION RELATED TO RECENTLY ENACTED TAX LEGISLATION IN U.S. ​

15 Feb 2018

BRIEF-Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4

* ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 Source text: (http://bit.ly/2qDYvyf) Further company coverage:

08 Jan 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $59.17 +0.72
Bayer AG (BAYGn.DE) €102.74 -2.30
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €66.23 -0.14
Eli Lilly And Co (LLY.N) $82.68 +0.46

Earnings vs. Estimates